Distinguishing Hits From False Positives and Other Challenges in Fragment Screening Using SPR Biosensor TechnologyTuesday, 19 March 2013 at 11:15 Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com The versatile experimental design and information rich output of SPR biosensors is particularly well suited for fragment based drug discovery. Case studies will illustrate how the technology can be applied in different steps of the drug discovery process. |